Literature DB >> 1282800

The level of a transcription factor Sp1 is correlated with the expression of EGF receptor in human gastric carcinomas.

Y Kitadai1, W Yasui, H Yokozaki, H Kuniyasu, K Haruma, G Kajiyama, E Tahara.   

Abstract

The expression of the transcription factor Sp1 and EGF receptor (EGFR) was examined on human gastric carcinoma cell lines and gastric carcinoma tissues as well as corresponding normal mucosa in order to clarify the mechanism of overexpression of EGFR gene without gene amplification. All 7 carcinoma cell lines expressed Sp1 mRNA, the levels of which were closely correlated with the expression of EGFR mRNA except for one cell line. The gel retardation analysis revealed that the levels of Sp1 mRNA were parallel to its DNA binding activities. In 18 surgical cases, 12 tumors expressed Sp1 mRNA at higher levels than normal mucosa. The cases with overexpression of Sp1 showed the high level of EGFR mRNA. These results suggest that overexpression of Sp1 in tumor cells may induce overexpression of EGFR without gene amplification in human gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282800     DOI: 10.1016/0006-291x(92)90221-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.

Authors:  D Mukhopadhyay; B Knebelmann; H T Cohen; S Ananth; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Functional characterization of the human translocator protein (18kDa) gene promoter in human breast cancer cell lines.

Authors:  Amani Batarseh; Keith D Barlow; Daniel B Martinez-Arguelles; Vassilios Papadopoulos
Journal:  Biochim Biophys Acta       Date:  2011-09-18

3.  Novel functional single nucleotide polymorphisms in the latent transforming growth factor-beta binding protein-1L promoter: effect on latent transforming growth factor-beta binding protein-1L expression level and possible prognostic significance in ovarian cancer.

Authors:  Tomomi Higashi; Satoru Kyo; Masaki Inoue; Hideji Tanii; Kiyofumi Saijoh
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

4.  ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter.

Authors:  J L Merchant; G R Iyer; B R Taylor; J R Kitchen; E R Mortensen; Z Wang; R J Flintoft; J B Michel; R Bassel-Duby
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

5.  Thiazolidinediones mimic glucose starvation in facilitating Sp1 degradation through the up-regulation of beta-transducin repeat-containing protein.

Authors:  Shuo Wei; Hsiao-Ching Chuang; Wan-Chi Tsai; Hsiao-Ching Yang; Shiuh-Rong Ho; Andrew J Paterson; Samuel K Kulp; Ching-Shih Chen
Journal:  Mol Pharmacol       Date:  2009-04-16       Impact factor: 4.436

6.  Epidermal growth factor receptor expression in oligodendroglial tumors.

Authors:  J Reifenberger; G Reifenberger; K Ichimura; E E Schmidt; W Wechsler; V P Collins
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 7.  Molecular biology of gastric cancer.

Authors:  E Tahara
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

8.  Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen.

Authors:  N E Gilhus; M Jones; H Turley; K C Gatter; N Nagvekar; J Newsom-Davis; N Willcox
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

9.  Specificity protein 1 is pivotal in the skin's antiviral response.

Authors:  Lianghua Bin; Michael D Howell; Byung Eui Kim; Joanne E Streib; Clifton F Hall; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2011-01-05       Impact factor: 10.793

10.  Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells.

Authors:  Hideki Tatsukawa; Tetsuro Sano; Yayoi Fukaya; Naoto Ishibashi; Makiko Watanabe; Masataka Okuno; Hisataka Moriwaki; Soichi Kojima
Journal:  Mol Cancer       Date:  2011-01-09       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.